Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Overview
Patent Analysis
Analysis of Porter’s Five Forces
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Future Perspective

Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Prevalence of Cancer Cases Globally
Rise in Government Funding and Pharmaceutical R&D Spending
Nanoparticles in Cancer Treatment: Advantages
Precision Targeting of Cancer Cells with Nanomaterials
Market Restraints
Roadblocks to Clinical Nanoparticle Use
Lack of Oncology Professionals
Market Opportunities
Mechanism of Nanoparticles in Overcoming Drug Resistance
Cancer Proteomics

Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Japan

Chapter 5 Emerging Technologies and New Developments
Emerging Trends and Technologies
Artificial Intelligence
Quantum Dots
Oncology Products Pipeline

Chapter 6 Market Segment Analysis
Segmentation Breakdown
Market Analysis by Product Type
Global Market Size and Forecast
Liposomes
Polymeric Nanoparticles
Micelles
Hydrogels
Dendrimers
Market Analysis by Cancer Type
Global Market Size and Forecast
Lung Cancer
Breast Cancer
Leukemia
Lymphoma
Melanoma
Other Cancers
Geographic Breakdown
Market Analysis by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Middle East and Africa
South America

Chapter 7 Competitive Intelligence
Overview
Competitive Landscape

Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ASTRAZENECA
BAXTER
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
JAZZ PHARMACEUTICALS INC.
LES LABORATOIRES SERVIER
NOVARTIS AG
PFIZER INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Other Emerging Players



List of Figures


Summary Figure : Global Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 1 : Market Dynamics of Nanotechnology in Cancer Treatment
Figure 2 : Breakdown of Most Frequent Cancers in Women, by Type, 2022
Figure 3 : Breakdown of Most Frequent Cancers in Men, by Type, 2022
Figure 4 : Estimated Cancer Incidence and Mortality Cases Globally, by Cancer Type, 2024
Figure 5 : Trends in NCI Funding for Cancer Research, by Year, 2012–2019
Figure 6 : Global Pharmaceutical R&D Spending, 2020–2026
Figure 7 : Global Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 8 : Global Market Shares of Nanotechnology-based Liposomes in Cancer Treatment, by Region, 2023
Figure 9 : Global Market Shares of Nanotechnology-based Polymeric Nanoparticles in Cancer Treatment, by Region, 2023
Figure 10 : Global Market Shares of Nanotechnology-based Micelles in Cancer Treatment, by Region, 2023
Figure 11 : Global Market Shares of Nanotechnology-based Hydrogels in Cancer Treatment, by Region, 2023
Figure 12 : Global Market Shares of Nanotechnology-based Dendrimers in Cancer Treatment, by Region, 2023
Figure 13 : Global Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 14 : Global Market Shares of Nanotechnology in Lung Cancer Treatment, by Region, 2023
Figure 15 : Global Market Shares of Nanotechnology in Breast Cancer Treatment, by Region, 2023
Figure 16 : Global Market Shares of Nanotechnology in Leukemia Cancer Treatment, by Region, 2023
Figure 17 : Global Market Shares of Nanotechnology in Lymphoma, by Region, 2023
Figure 18 : Global Market Shares of Nanotechnology in Melanoma Treatment, by Region, 2023
Figure 19 : Global Market Shares of Nanotechnology in Other Cancers, by Region, 2023
Figure 20 : Global Market Shares of Nanotechnology in Cancer Treatment, by Region, 2023
Figure 21 : North American Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 22 : North American Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 23 : North American Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
Figure 24 : European Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 25 : European Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 26 : European Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
Figure 27 : Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 28 : Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 29 : Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
Figure 30 : Middle East and African Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 31 : Middle East and African Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 32 : South American Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 33 : South American Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 34 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 35 : AstraZeneca: Revenue Share, by Country/Region, FY 2023
Figure 36 : Baxter: Revenue Share, by Business Unit, FY 2023
Figure 37 : Baxter: Revenue Share, by Country/Region, FY 2023
Figure 38 : Boston Scientific Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 39 : Boston Scientific Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 40 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 41 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 42 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 43 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 44 : Jazz Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 45 : Jazz Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 46 : Les Laboratoires Servier: Revenue Share, by Business Unit, FY 2023
Figure 47 : Les Laboratoires Servier: Revenue Share, by Region, FY 2023
Figure 48 : Novartis AG: Revenue Share, by Business Unit, FY 2023
Figure 49 : Novartis AG: Revenue Share, by Country/Region, FY 2023
Figure 50 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2023
Figure 51 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
Figure 52 : Teva Pharmaceutical Industries Ltd.: Market Share, by Business Unit, FY 2023
Figure 53 : Teva Pharmaceutical Industries Ltd.: Market Share, by Region, FY 2023

List of Tables


Summary Table : Global Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 1 : Select Patent Grants on Nanotechnology in Cancer Treatment, 2024 and 2025
Table 2 : Porter’s Five Forces Analysis: Nanotechnology in Cancer Treatment Market
Table 3 : Selected Clinical Trials Studies on Nanotechnology in Cancer Treatment, 2024
Table 4 : Global Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 5 : Global Market for Nanotechnology-based Liposomes in Cancer Treatment, by Region, Through 2029
Table 6 : Global Market for Nanotechnology-based Polymeric Nanoparticles in Cancer Treatment, by Region, Through 2029
Table 7 : Global Market for Nanotechnology-based Micelles in Cancer Treatment, by Region, Through 2029
Table 8 : Global Market for Nanotechnology-based Hydrogels in Cancer Treatment, by Region, Through 2029
Table 9 : Global Market for Nanotechnology-based Dendrimers in Cancer Treatment, by Region, Through 2029
Table 10 : Global Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 11 : Global Market for Nanotechnology in Lung Cancer Treatment, by Region, Through 2029
Table 12 : Global Market for Nanotechnology in Breast Cancer Treatment, by Region, Through 2029
Table 13 : Global Market for Nanotechnology in Leukemia Cancer Treatment, by Region, Through 2029
Table 14 : Global Market for Nanotechnology in Lymphoma, by Region, Through 2029
Table 15 : Global Market for Nanotechnology in Melanoma Treatment, by Region, Through 2029
Table 16 : Global Market for Nanotechnology in Other Cancers, by Region, Through 2029
Table 17 : Global Market for Nanotechnology in Cancer Treatment, by Region, Through 2029
Table 18 : North American Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 19 : North American Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 20 : North American Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
Table 21 : European Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 22 : European Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 23 : European Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
Table 24 : Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 25 : Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 26 : Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
Table 27 : Middle East and African Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 28 : Middle East and African Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 29 : South American Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 30 : South American Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 31 : Major Market Players in Nanotechnology in Cancer Treatment, 2023
Table 32 : Abbreviations Used in this Report
Table 33 : Information Sources in this Report
Table 34 : AstraZeneca: Company Snapshot
Table 35 : AstraZeneca: Financial Performance, FY 2022 and 2023
Table 36 : AstraZeneca: Product Portfolio
Table 37 : AstraZeneca: News/Key Developments, 2023 and 2024
Table 38 : Baxter: Company Snapshot
Table 39 : Baxter: Financial Performance, FY 2022 and 2023
Table 40 : Baxter: Product Portfolio
Table 41 : Baxter: News/Key Developments, 2021
Table 42 : Boston Scientific Corp.: Company Snapshot
Table 43 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 44 : Boston Scientific Corp.: Product Portfolio
Table 45 : Boston Scientific Corp.: News/Key Developments, 2021
Table 46 : Bristol-Myers Squibb Co.: Company Snapshot
Table 47 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 48 : Bristol-Myers Squibb Co.: Product Portfolio
Table 49 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 50 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 51 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 52 : Jazz Pharmaceuticals Inc.: Company Snapshot
Table 53 : Jazz Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 54 : Jazz Pharmaceuticals Inc.: Product Portfolio
Table 55 : Les Laboratoires Servier: Company Snapshot
Table 56 : Les Laboratoires Servier: Financial Performance, FY 2022 and 2023
Table 57 : Les Laboratoires Servier: Product Portfolio
Table 58 : Les Laboratoires Servier: News/Key Developments, 2023 and 2024
Table 59 : Novartis AG: Company Snapshot
Table 60 : Novartis AG: Financial Performance, FY 2022 and 2023
Table 61 : Novartis AG: Product Portfolio
Table 62 : Pfizer Inc.: Company Snapshot
Table 63 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 64 : Pfizer Inc.: Product Portfolio
Table 65 : Pfizer Inc.: News/Key Developments, 2023
Table 66 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 67 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 68 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 69 : Few Emerging Players in Nanotechnology in Cancer Treatment Market